Yahoo
NasdaqCM - Nasdaq Real Time Price USD

Liminatus Pharma, Inc. (LIMN)

2.5200 -0.2300 (-8.36%)
At close: 4:00:00 PM EST
2.5100 -0.0100 (-0.40%)
After hours: 4:15:07 PM EST
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
0
0
0
0
0
Operating Expense
4,065.1870
2,967.8120
3,329.9530
4,819
2,709
Operating Income
-4,065.1870
-2,967.8120
-3,329.9530
-4,819
-2,709
Net Non Operating Interest Income Expense
-67.3620
-139.3140
-216.3560
-165
-219
Other Income Expense
-8,390.7020
-7,099.3910
--
--
--
Pretax Income
-12,523.2510
-10,206.5170
-3,546.3090
-4,984
-2,928
Net Income Common Stockholders
-12,523.2510
-10,206.5170
-3,546.3090
-4,984
-2,928
Diluted NI Available to Com Stockholders
-12,523.2510
-10,206.5170
-3,546.3090
-4,984
-2,928
Basic EPS
-0.48
-0.43
-0.14
-0.19
-0.11
Diluted EPS
-0.48
-0.43
-0.14
-0.19
-0.11
Basic Average Shares
34,669.8680
23,753.5610
26,014.6330
26,014.6330
26,014.6330
Diluted Average Shares
34,669.8680
23,753.5610
26,014.6330
26,014.6330
26,014.6330
Total Operating Income as Reported
-4,065.1870
-2,967.8120
-3,329.9530
-4,819
-2,709
Total Expenses
4,065.1870
2,967.8120
3,329.9530
4,819
2,709
Net Income from Continuing & Discontinued Operation
-12,523.2510
-10,206.5170
-3,546.3090
-4,984
-2,928
Normalized Income
-10,932.5490
-10,663.1260
-3,546.3090
-4,984
-2,928
Interest Income
8.2230
76.5890
122.5260
10
0
Interest Expense
75.5850
215.9030
338.8820
175
219
Net Interest Income
-67.3620
-139.3140
-216.3560
-165
-219
EBIT
-12,447.6660
-9,990.6140
-3,207.4270
-4,809
-2,709
EBITDA
-12,445.5950
-9,988.7860
-3,207.4270
-4,809
-2,709
Reconciled Depreciation
2.0710
1.8280
0
--
--
Net Income from Continuing Operation Net Minority Interest
-12,523.2510
-10,206.5170
-3,546.3090
-4,984
-2,928
Total Unusual Items Excluding Goodwill
-1,590.7020
456.6090
0
--
--
Total Unusual Items
-1,590.7020
456.6090
0
--
--
Normalized EBITDA
-10,854.8930
-10,445.3950
-3,207.4270
-4,809
-2,709
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2022 - 5/2/2025

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: